Gene expression changes in colon tissues from colorectal cancer patients following the intake of an ellagitannin-containing pomegranate extract: a randomized clinical trial

Journal of Nutritional Biochemistry

Volumn 42, Issue , 2017, Pages 126-133

  Nuñez Sánchez, María A ^a   González Sarrías, Antonio ^a   García Villalba, Rocío ^a   Monedero Saiz, Tamara ^a,b   García Talavera, Noelia V ^b   Gómez Sánchez, María B ^b   Sánchez Álvarez, Carmen ^b   García Albert, Ana M ^b   Rodríguez Gil, Francisco J ^b   Ruiz Marín, Miguel ^b   Pastor Quirante, Francisco A ^b   Martínez Díaz, Francisco ^b   Tomás Barberán, Francisco A ^a   Espín, Juan Carlos ^a   García Conesa, María Teresa ^a  

^a RESEARCH GROUP ON QUALITY   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Clinical trial; Colon tissues; Ellagitannins; Gene expression; Interindividual variability; Pomegranate extract; Urolithins

Indexed keywords

ANTINEOPLASTIC AGENT; COMPLEMENTARY DNA; ELLAGITANNIN; MESSENGER RNA; POMEGRANATE EXTRACT; PUNICALAGIN; PUNICALIN; UNCLASSIFIED DRUG; PLANT EXTRACT; TANNIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CASP3 GENE; CD44 GENE; CDKN1A GENE; COLON TISSUE; COLORECTAL CANCER; CONTROLLED STUDY; CTNNB1 GENE; DIET SUPPLEMENTATION; EGFR GENE; FEMALE; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MICROCAPSULE; ONCOGENE K RAS; ONCOGENE MYC; RANDOMIZED CONTROLLED TRIAL; TISSUE SPECIFICITY; TYM GENE; CHEMISTRY; COLORECTAL TUMOR; DIET THERAPY; GENE EXPRESSION REGULATION; GENETICS; LYTHRACEAE; REPRODUCIBILITY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROLYZABLE TANNINS; MALE; PLANT EXTRACTS; PUNICACEAE; REPRODUCIBILITY OF RESULTS;

EID: 85011579918     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2017.01.014     Document Type: Article

References (39)

1. [1] García-Conesa, M.T., Dietary polyphenols against metabolic disorders: how far have we progressed in the understanding of the molecular mechanisms of action of these compounds?. Crit Rev Food Sci Nutr, 2015, 10.1080/10408398.2014.980499.
2. [2] Manach, C., Milenkovic, D., Van de Wiele, T., Rodriguez-Mateos, A., de Roos, B., Garcia-Conesa, M.T., et al. Addressing the inter-individual variation in response to consumption of plant food bioactives — towards a better understanding of their role in healthy ageing and cardiometabolic risk reduction. Mol Nutr Food Res, 2016, 10.1002/mnfr.201600557.
3. [3] Cerdá, B., Espín, J.C., Parra, S., Martínez, P., Tomás-Barberán, F.A., The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxyl-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans. Eur J Nutr 43 (2004), 205–220.
4. [4] Cerdá, B., Periago, P., Espín, J.C., Tomás-Barberán, F.A., Identification of urolithin a as a metabolite produced by human colon microflora from related compounds. J Agric Food Chem 53 (2005), 5571–5576.
5. [5] Cerdá, B., Tomás-Barberán, F.A., Espín, J.C., Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: identification of biomarkers and individual variability. J Agric Food Chem 53 (2005), 227–235.
6. [6] Espín, J.C., González-Barrio, R., Cerdá, B., López-Bote, C., Rey, A.I., Tomás-Barberán, F.A., Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans. J Agric Food Chem 55 (2007), 10476–10485.
7. [7] Selma, M.V., Romo-Vaquero, M., García-Villalba, R., González-Sarrías, A., Tomás-Barberán, F.A., Espín, J.C., The human gut microbial ecology associated with overweight and obesity determines ellagic acid metabolism. Food Funct 7 (2016), 1769–1774.
8. [8] Núñez-Sánchez, M.A., García-Villalba, R., Monedero-Saiz, T., García-Talavera, N.V., Gómez-Sánchez, M.B., Sánchez-Álvarez, C., et al. Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patients. Mol Nutr Food Res 58 (2014), 1199–1211.
9. [9] Tomás-Barberán, F.A., García-Villalba, R., González-Sarrías, A., Selma, M.V., Espín, J.C., Ellagic acid metabolism by human gut microbiota: consistent observation of three urolithin phenotypes intervention trials, independent of food source, age, and health status. J Agric Food Chem 62 (2014), 6535–6538.
10. [10] Tomás-Barberán, F.A., González-Sarrías, A., García-Villalba, R., Núñez-Sánchez, M.A., Selma, M.V., García-Conesa, M.T., et al. Urolithins, the rescue of ‘old’ metabolites to understand a ‘new’ concept: metabotypes as a nexus between phenolic metabolism, microbiota dysbiosis and host health status. Mol Nutr Food Res, 2016, 10.1002/mnfr.201500901.
11. [11] González-Sarrías, A., Espín, J.C., Tomás-Barberán, F.A., García-Conesa, M.T., Gene expression, cell cycle arrest and MAPK signalling regulation in Caco-2 cells exposed to ellagic acid and its metabolites, urolithins. Mol Nutr Food Res 53 (2009), 686–698.
12. [12] González-Sarrías, A., Núñez-Sánchez, M.A., Tomé-Carneiro, J., Tomás-Barberán, F.A., García-Conesa, M.T., Espín, J.C., Comprehensive characterization of the effects of ellagic acid and urolithins on colorectal cancer and key associated molecular hallmarks: microRNA-cell specific induction on CDKN1A (p21) as a common mechanism involved. Mol Nutr Food Res 60 (2016), 701–716.
13. [13] Núñez-Sánchez, M.A., González-Sarrías, A., Romo-Vaquero, M., García-Villalba, R., Selma, M.V., Tomás-Barberán, F.A., et al. Dietary phenolics against colorectal cancer — from promising preclinical results to poor translation into clinical trials: pitfalls and future needs. Mol Nutr Food Res 59 (2015), 1274–1291.
14. [14] Núñez-Sánchez, M.A., Dávalos, A., González-Sarrías, A., Casas-Agustench, P., Visioli, F., Monedero-Saiz, T., et al. MicroRNAs expression in normal and malignant colon tissues as biomarkers of colorectal cancer and in response to pomegranate extracts consumption: critical issues to discern between modulatory effects and potential artefacts. Mol Nutr Food Res 59 (2015), 1973–1986.
15. [15] Menyhárt, O., Harami-Papp, H., Sukumar, S., Schäfer, R., Magnani, L., de Barrios, O., et al. Guidelines for the selection of functional assays to evaluate the hallmarks of cancer. Biochim Biophys Acta 2016 (1866), 300–319.
16. [16] Schroeder, A., Mueller, O., Stocker, S., Salowsky, R., Leiber, M., Gassmann, M., et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol, 7, 2006, 3.
17. [17] Sørby, L.A., Andersen, S.N., Bukholm, I.R., Jacobsen, M.B., Evaluation of suitable reference genes for normalization of real-time reverse transcription PCR analysis in colon cancer. J Exp Clin Cancer Res, 29, 2010, 144.
18. [18] Dowling, C.M., Walsh, D., Coffey, J.C., Kiely, P.A., The importance of selecting the appropriate reference genes for quantitative real time PCR as illustratedusing colon cancer cells and tissue. F1000Res, 5, 2016, 99.
19. [19] Wang, H., Yang, B., Geng, T., Li, B., Dai, P., Chen, C., Tissue-specific selection of optimal reference genes for expression analysis of anti-cancer drug-relatedgenes in tumor samples using quantitative real-time RT-PCR. Exp Mol Pathol 98 (2015), 375–381.
20. [20] Andersen, C.L., Ledet-Jensen, J., Ørntoft, T., Normalization of real-time quantitative RT-PCR data a model-based variance estimation approach to identify genes suited for normalization applied to bladder and colon cancer data sets. Cancer Res 64 (2004), 5245–5250.
21. [21] Bourgine, J., Billaut-Laden, I., Happillon, M., Lo-Guidice, J.M., Maunoury, V., Imbenotte, M., et al. Gene expression profiling of systems involved in the metabolism and the disposition of xenobiotics: comparison between human intestinal biopsy samples and colon cell lines. Drug Metab Dispos 40 (2012), 694–705.
22. [22] Bukholm, I.K., Nesland, J.M., Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas. Virchows Arch 436 (2000), 224–228.
23. [23] Chu, C.M., Yao, C.T., Chang, Y.T., Chou, H.L., Chou, Y.C., Chen, K.H., et al. Gene expression profiling of colorectal tumors and normal mucosa microarrays meta-analysis using prediction analysis of microarray, artificial neural network, classification, and regression trees. Dis Markers, 2014, 2014, 634123.
24. [24] Arnold, C.N., Goel, A., Niedzwiecki, D., Dowell, J.M., Wasserman, L., Compton, C., et al. APC promoter hypermethylation contributes to the loss of APC expression in colorectal cancers with allelic loss on 5q. Cancer Biol Ther 3 (2004), 960–964.
25. [25] Chan, S.K., Griffiyh, O.L., Tai, I.T., Jones, S.J.M., Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers. Cancer Epidemiol Biomarkers Prev 17 (2008), 543–552.
26. [26] Suhovskih, A.V., Aidagulova, S.V., Kashuba, V.I., Grigorieva, E.V., Proteoglycans as potential microenvironmental biomarkers for colon cancer. Cell Tissue Res 361 (2015), 833–844.
27. [27] Williams, N.S., Gaynor, R.B., Scoggin, S., Verma, U., Gokaslan, T., Simmang, C., et al. Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. Clin Cancer Res 9 (2003), 931–946.
28. [28] Gowda, B., Qin, J., Morbarhan, S., Frommel, T.O., Expression of c-myc in human colonic tissue in response to beta-carotene supplementation. Nutr Cancer 28 (1997), 135–139.
29. [29] Frommel, T.O., Leitz, H., Mobarhan, S., Expression of mRNA for the gap-junctional protein connexin43 in human colonic tissue is variable in response to beta-carotene supplementation. Nutr Cancer 22 (1994), 257–265.
30. [30] Pufelete, M., Abbadi, R.A.G., Arno, M., Ewins, M., Green, C., Astarloa, E.A., et al. The influence of folate supplementation on global gene expression in normal colonic mucosa of subjects with colorectal adenoma. Mol Nutr Food Res 57 (2013), 709–720.
31. [31] Nguyen, A.V., Martinez, M., Stamos, M.J., Moyer, M.P., Planutis, K., Hope, C., et al. Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manag Res 1 (2009), 25–37.
32. [32] Alemu, E.Y., Carl, J.W. Jr., Corrada Bravo, H., Hannenhalli, S., Determinants of expression variability. Nucleic Acids Res 2 (2014), 3503–3514.
33. [33] David, K.A., Unger, F.T., Uhlig, P., Juhl, H., Moore, H.M., Compton, C., et al. Surgical procedures and postsurgical tissue processing significantly affect expression of genes and EGFR-pathway proteins in colorectal cancer tissue. Oncotarget 5 (2014), 11017–11028.
34. [34] Musella, V., Verderio, P., Reid, J.F., Pizzamiglio, S., Gariboldi, M., Callari, M., et al. Effects of warm ischemic time on gene expression profiling in colorectal cancer tissues and normal mucosa. PLoS One, 8, 2013, e53406.
35. [35] Sánchez-González, C., Ciudad, C.J., Izquierdo-Pulido, M., Noé, V., Urolithin a causes p21 up-regulation in prostate cancer cells. Eur J Nutr, 55, 2016 [1099-12].
36. [36] Li, Z., Henning, S.M., Lee, R.P., Lu, Q.Y., Summanen, P.H., Thames, G., et al. Pomegranate extract induces ellagitannin metabolite formation and changes stool microbiota in healthy volunteers. Food Funct 6 (2015), 2487–2495.
37. [37] Gagnon, M., Zihler Berner, A., Chervet, N., Chassard, C., Lacroix, C., Comparison of the Caco-2, HT-29 and the mucus-secreting HT29-MTX intestinal cell models to investigate Salmonella adhesion and invasion. J Microbiol Methods 94 (2013), 274–279.
38. [38] D'Agostino, E.M., Rossetti, D., Atkins, D., Ferdinando, D., Yakubov, G.E., Interaction of tea polyphenols and food constituents with model gut epithelia: the protective role of the mucus gel layer. J Agric Food Chem 60 (2012), 3318–3328.
39. [39] Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., et al. Global quantification of mammalian gene expression control. Nature 473 (2011), 337–342.